NCT02344849View on ClinicalTrials.gov

Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

April 30, 2018

Conditions
Erectile Dysfunction
Interventions
DRUG

mesenchymal stem cell

Patients will receive single injection of Cellgram-ED( 30,000,000 mesenchymal stem cell) intracavernously.

Trial Locations (1)

Unknown

Asan medical center, Seoul

All Listed Sponsors
lead

Pharmicell Co., Ltd.

INDUSTRY

NCT02344849 - Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction | Biotech Hunter | Biotech Hunter